[Kidney disease care for the elderly]

Nephrol Ther. 2019 Dec;15(7):533-552. doi: 10.1016/j.nephro.2019.10.001. Epub 2019 Nov 9.
[Article in French]

Abstract

In our aging population, kidney disease management needs to take into account the frailty of the elderly. Standardized geriatric assessments can be proposed to help clinicians apprehend this dimension in their daily practice. These tools allow to better identify frail patients and offer them more personalized and harmless treatments. This article aims to focus on the kidney diseases commonly observed in elderly patients and analyze their specific nephrogeriatric care modalities. It should be noticed that all known kidney diseases can be also observed in the elderly, most often with a quite similar clinical presentation. This review is thus focused on the diseases most frequently and most specifically observed in elderly patients (except for monoclonal gammopathy associated nephropathies, out of the scope of this work), as well as the peculiarities of old age nephrological care.

Keywords: Aging; Diabetes; Diabète; Fragilité; Frailty; Geriatrics; Gériatrie; Hypertensive nephropathy; Kidney disease; Néphropathie; Néphropathie vasculaire; Vascularites; Vasculitis; Vieillissement.

Publication types

  • Review

MeSH terms

  • Age Distribution
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Antihypertensive Agents / therapeutic use
  • Biopsy
  • Comorbidity
  • Diabetic Nephropathies / diagnosis
  • Diabetic Nephropathies / epidemiology
  • Diabetic Nephropathies / therapy
  • Disease Management
  • Dyslipidemias / drug therapy
  • Dyslipidemias / epidemiology
  • Embolism, Cholesterol / epidemiology
  • Female
  • Frail Elderly
  • Humans
  • Hypertension / epidemiology
  • Hypertension / etiology
  • Hypoglycemic Agents / therapeutic use
  • Hypolipidemic Agents / therapeutic use
  • Kidney Diseases / classification
  • Kidney Diseases / diagnosis
  • Kidney Diseases / epidemiology
  • Kidney Diseases / therapy*
  • Male
  • Precision Medicine
  • Randomized Controlled Trials as Topic
  • Risk

Substances

  • Antihypertensive Agents
  • Hypoglycemic Agents
  • Hypolipidemic Agents